Medicare Program: Announcement of the Advisory Panel on Hospital Outpatient Payment (the Panel) Meeting on August 20-21, 2018, 19785-19787 [2018-09532]
Download as PDF
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
[FR Doc. 2018–09430 Filed 5–3–18; 8:45 a.m.]
BILLING CODE 4120–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1707–N]
Medicare Program: Announcement of
the Advisory Panel on Hospital
Outpatient Payment (the Panel)
Meeting on August 20–21, 2018
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (DHHS).
ACTION: Notice.
AGENCY:
This notice announces the
annual meeting of the Advisory Panel
on Hospital Outpatient Payment (the
Panel) for 2018. The purpose of the
Panel is to advise the Secretary of
Department of Health and Human
Services and the Administrator of the
Centers for Medicare & Medicaid
Services concerning the clinical
integrity of the Ambulatory Payment
Classification groups and their
associated weights as well as hospital
outpatient therapeutic services
supervision issues. The advice provided
by the Panel will be considered as we
prepare the annual updates for the
hospital outpatient prospective payment
system.
DATES:
Meeting Dates: Monday, August 20,
2018, 9:30 a.m. to 5 p.m. EDT through
Tuesday, August 21, 2018, 9:30 a.m. to
1 p.m. EDT.
The times listed in this notice are
Eastern Daylight Time (EDT) and are
approximate times. Consequently, the
meetings may last longer or be shorter
than the times listed in this notice, but
will not begin before the posted times:
Meeting Information Updates: The
actual meeting hours and days will be
posted in the agenda. As information
and updates regarding the onsite,
webcast, and teleconference meeting
and the agenda become available, they
will be posted to our website at: https://
cms.gov/Regulations-and-Guidance/
Guidance/FACA/AdvisoryPanelon
AmbulatoryPaymentClassification
Groups.html.
Deadline for Presentations and
Comments: Presentations or comments
and form CMS–20017, (located at
https://www.cms.gov/Medicare/CMSForms/CMS-Forms/downloads/
cms20017.pdf) must be received by 5
p.m. EDT, Monday, July 23, 2018.
Presentations and comments that are not
amozie on DSK3GDR082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
received by the due date and time will
be considered late and will not be
included on the agenda. In commenting,
refer to file code CMS–1707–N.
Meeting Registration Timeframe:
Monday, June 25, 2018, through
Monday, July 30, 2018 at 5 p.m. EDT.
Participants planning to attend this
meeting in person must register online,
during the specified timeframe at:
https://www.cms.gov/apps/events/
default.asp. On this web page, double
click the ‘‘Upcoming Events’’ hyperlink,
and then double click the ‘‘HOP Panel’’
event title link and enter the required
information. Include any requests for
special accommodations.
Note: Participants who do not plan to
attend the meeting in person should not
register. No registration is required for
participants who plan to participate in the
meeting via webcast or teleconference.
Because of staff and resource
limitations, we cannot accept comments
and presentations by facsimile (FAX)
transmission.
Deadline for Requesting Special
Accommodations: Monday, July 30,
2018 at 5 p.m. EDT.
ADDRESSES:
Meeting Location, Webcast, and
Teleconference.
The meeting will be held in the
Auditorium at the CMS Single Site
campus, 7500 Security Boulevard,
Baltimore, MD 21244. Alternately, the
public may either view this meeting via
a webcast or listen by teleconference.
During the scheduled meeting,
webcasting is accessible online at:
https://cms.gov/live. Teleconference dialin information will appear on the final
meeting agenda, which will be posted
on our website when available at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/
AdvisoryPanelonAmbulatoryPayment
ClassificationGroups.html.
News Media. Press inquiries are
handled through the CMS Press Office
at (202) 690–6145.
Advisory Committees’ Information
Lines. The phone number for the CMS
Federal Advisory Committee Hotline is
(410) 786–3985.
Websites. For additional information
on the Panel, including the Panel
charter, and updates to the Panel’s
activities, we refer readers to view our
website at: https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/AdvisoryPanelonAmbulatory
PaymentClassificationGroups.html.
Information about the Panel and its
membership in the Federal Advisory
Committee Act database are also located
at: https://facadatabase.gov/.
Registration: The meeting is open to
the public; but attendance is limited to
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
19785
the space available and registration is
required. Priority will be given to those
who pre-register and attendance may be
limited based on the number of
registrants and the space available.
Persons wishing to attend this
meeting, which is located on federal
property, must register by following the
instructions in the DATES section of this
notice under ‘‘Meeting Registration
Timeframe’’. A confirmation email will
be sent to the registrants shortly after
completing the registration process.
FOR FURTHER INFORMATION CONTACT:
Elise Barringer, Designated Federal
Official (DFO), 410–786–9222, email at
APCPanel@cms.hhs.gov. Centers for
Medicare & Medicaid Services, 7500
Security Boulevard, Mail Stop: C4–04–
25, Baltimore, MD 21244–1850.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary of the Department of
Health and Human Services (DHHS) is
required by section 1833(t)(9)(A) of the
Social Security Act (the Act) and is
allowed by section 222 of the Public
Health Service Act (PHS Act) to consult
with an expert outside panel, such as
the Advisory Panel on Hospital
Outpatient Payment (the Panel),
regarding the clinical integrity of the
Ambulatory Payment Classification
(APC) groups and relative payment
weights. The Panel is governed by the
provisions of the Federal Advisory
Committee Act (Pub. L. 92–463), as
amended (5 U.S.C. Appendix 2), to set
forth standards for the formation and
use of advisory panels. We consider the
technical advice provided by the Panel
as we prepare the proposed and final
rules to update the Hospital Outpatient
Prospective Payment System (OPPS) for
the following calendar year.
II. Meeting Agenda
The agenda for the August 20 through
August 21, 2018 Panel meeting will
provide for discussion and comment on
the following topics as designated in the
Panel’s Charter:
• Addressing whether procedures
within an APC group are similar both
clinically and in terms of resource use.
• Evaluating APC group structure.
• Reviewing the packaging of OPPS
services and costs, including the
methodology and the impact on APC
groups and payment.
• Removing procedures from the
inpatient-only list for payment under
the OPPS.
• Using single and multiple
procedure claims data for Center for
Medicare & Medicaid’s (CMS’)
determination of APC group weights.
E:\FR\FM\04MYN1.SGM
04MYN1
19786
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
• Addressing other technical issues
concerning APC group structure.
• Recommending the appropriate
supervision level (general, direct, or
personal) for individual hospital
outpatient therapeutic services.
The Agenda will be posted on our
website at: https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/AdvisoryPanelonAmbulatory
PaymentClassificationGroups.html
approximately 1 week before the
meeting.
amozie on DSK3GDR082PROD with NOTICES
III. Presentations
The subject matter of any presentation
and comment matter must be within the
scope of the Panel designated in the
Charter. Any presentations or comments
outside of the scope of this Panel will
be returned or requested for
amendment. Unrelated topics include,
but are not limited to, the conversion
factor, charge compression, revisions to
the cost report, pass-through payments,
correct coding, new technology
applications (including supporting
information/documentation), provider
payment adjustments, supervision of
hospital outpatient diagnostic services,
and the types of practitioners that are
permitted to supervise hospital
outpatient services. The Panel may not
recommend that services be designated
as nonsurgical extended duration
therapeutic services.
The Panel may use data collected or
developed by entities and organizations
other than DHHS and CMS in
conducting its review. We recommend
organizations submit data for CMS staff
and the Panel’s review.
All presentations are limited to 5
minutes, regardless of the number of
individuals or organizations represented
by a single presentation. Presenters may
use their 5 minutes to represent either
1 or more agenda items.
Section 508 Compliance
For this meeting, we are aiming to
have all presentations and comments
available on our website. Materials on
our website must be Section 508
compliant to ensure access to federal
employees and members of the public
with and without disabilities. We
encourage presenters and commenters
to reference the guidance on making
documents Section 508 compliant as
they draft their submissions, and,
whenever possible, to submit their
presentations and comments in a 508
compliant form. Such guidance is
available at: https://www.cms.gov/
Research-Statistics-Data-and-Systems/
CMS-Information-Technology/
Section508/508-Compliant-doc.html.
We will review presentations and
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
comments for 508 compliance and place
compliant materials on our website. As
resources permit, we will also convert
non-compliant submissions to 508
compliant forms and offer assistance to
submitters who wish to make their
submissions 508 compliant. All non-508
compliant presentations and comments
will be shared with the public onsite
and through the webcast and made
available to the public upon request.
Those wishing to access such
materials should contact the DFO (the
DFO’s address, email, and phone
number are provided in the FOR FURTHER
INFORMATION CONTACT section of this
notice).
In order to consider presentations
and/or comments, we will need to
receive the following:
1. An email copy of the presentation
or comments sent to the DFO mailbox,
APCPanel@cms.hhs.gov or, if unable to
submit by email, a hard copy sent to the
DFO at the address noted in the FOR
FURTHER INFORMATION CONTACT section of
this notice.
2. Form CMS–20017 with complete
contact information that includes name,
address, phone number, and email
addresses for all presenters and
commenters and a contact person that
can answer any questions, and provide
revisions that are requested, for the
presentation. Presenters and
commenters must clearly explain the
actions that they are requesting CMS to
take in the appropriate section of the
form. A presenter’s or commenter’s
relationship with the organization that
they represent must also be clearly
listed.
• The form is now available through
the CMS Forms website at: https://
www.cms.gov/Medicare/CMS-Forms/
CMS-Forms/downloads/cms20017.pdf.
• We encourage presenters to make
efforts to ensure that their presentations
and comments are 508 compliant.
IV. Oral Comments
In addition to formal oral
presentations (limited to 5 minutes total
per presentation), there will be an
opportunity during the meeting for
public oral comments (limited to 1
minute for each individual) and a total
of 3 minutes per organization.
V. Panel Recommendations and
Discussions
The Panel’s recommendations at any
Panel meeting generally are not final
until they have been reviewed and
approved by the Panel on the last day
of the meeting, before the final
adjournment. These recommendations
will be posted to our website after the
meeting.
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
VI. Security, Building, and Parking
Guidelines
The meeting is open to the public, but
attendance is limited to the space
available. Persons wishing to attend this
meeting must register by contacting the
DFO at the address listed in the
ADDRESSES section of this notice or by
telephone at the number listed in the
FOR FURTHER INFORMATION CONTACT
section of this notice by the date
specified in the DATES section of this
notice.
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. We
recommend that confirmed registrants
arrive reasonably early, but no earlier
than 45 minutes prior to the start of the
meeting, to allow additional time to
clear security. Security measures
include the following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means of all persons
brought entering the building. We note
that all items brought into CMS,
whether personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 45 minutes prior to the
convening of the meeting.
All visitors must be escorted in areas
other than the lower and first floor
levels in the Central Building.
VII. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
E:\FR\FM\04MYN1.SGM
04MYN1
Federal Register / Vol. 83, No. 87 / Friday, May 4, 2018 / Notices
Dated: April 23, 2018.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
incorrect docket number. This
document corrects that error.
Lisa
Granger, Office of Policy and Planning,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, Rm.
3330, Silver Spring, MD 20993–0002,
301–796–9115.
SUPPLEMENTARY INFORMATION: In the
Federal Register of Tuesday, April 9,
2018 (83 FR 15152), in FR Doc. 2018–
07147, on page 15152, the following
correction is made:
1. On page 15152, in the second
column, in the first line of the list of
docket numbers, ‘‘FDA–2014–N–0075’’
is corrected to read ‘‘FDA–2011–N–
0075.’’
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2011–N–0075; FDA–
2011–N–0015; FDA–2011–N–0076; FDA–
2017–N–0932; FDA–2016–N–4487; FDA–
2014–N–0345; FDA–2013–N–0523; FDA–
2017–N–2428; FDA–2008–N–0312; and
FDA–2014–N–1072]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals;
Correction
AGENCY:
Food and Drug Administration,
Dated: April 30, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–09437 Filed 5–3–18; 8:45 am]
BILLING CODE 4164–01–P
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration is correcting a notice
entitled ‘‘Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals’’
that appeared in the Federal Register of
April 9, 2018. The document announced
a list of information collections that
have been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
The document was published with an
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–1534]
Sun Pharmaceutical Industries, Ltd.;
Withdrawal of Approval of Three
Abbreviated New Drug Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
The Food and Drug
Administration (FDA or Agency) is
withdrawing approval of three
abbreviated new drug applications
(ANDAs) held by Sun Pharmaceutical
Industries, Ltd., c/o Sun Pharmaceutical
Industries, Inc. (Sun Pharmaceutical).
These drug products are no longer
marketed, and Sun Pharmaceutical has
requested that the approval of the
applications be withdrawn.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2018–09532 Filed 5–3–18; 8:45 am]
19787
Notice.
Approval is withdrawn as of
June 4, 2018.
DATES:
FOR FURTHER INFORMATION CONTACT:
Trang Tran, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 75, Rm. 1671, Silver Spring,
MD 20993–0002, 240–402–7945,
Trang.Tran@fda.hhs.gov.
Sun
Pharmaceutical has informed FDA that
these drug products are no longer
marketed and requested that FDA
withdraw approval of the applications.
Sun Pharmaceutical has also waived its
opportunity for a hearing and requested
withdrawal of approval under a Consent
Decree of Permanent Injunction (Decree)
entered in United States v. Ranbaxy
Laboratories, Ltd. et al., JFM 12–250 (D.
Md.) on January 26, 2012. The Decree
specifies that Sun Pharmaceutical must
never submit another application to
FDA for these withdrawn drugs and
must never transfer these ANDAs to a
third party.
SUPPLEMENTARY INFORMATION:
Application No.
Drug
Applicant
ANDA 065174 .........
Clarithromycin Tablets USP, 250 milligrams (mg) and 500
mg.
ANDA 065382 .........
Clarithromycin for Oral Suspension USP, 125 mg/5 milliliters (mL) and 250 mg/5 mL.
Ciprofloxacin Tablets USP, Equivalent to (EQ) 250 mg
base, EQ 500 mg base, and EQ 750 mg base.
Sun Pharmaceutical Industries, Ltd., c/o Sun Pharmaceutical Industries, Inc., 2 Independence Way, Princeton,
NJ 08540.
Do.
ANDA 075747 .........
Do.
amozie on DSK3GDR082PROD with NOTICES
Therefore, approval of the
applications listed in the above table,
and all amendments and supplements
thereto, is hereby withdrawn as of June
4, 2018. Introduction or delivery for
introduction into interstate commerce of
products without approved new drug
applications violates section 301(a) and
(d) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 331(a) and (d)).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 1, 2018.
Leslie Kux,
Associate Commissioner for Policy.
HHS.
[FR Doc. 2018–09533 Filed 5–3–18; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
18:16 May 03, 2018
Jkt 244001
Food and Drug Administration
[Docket No. FDA–2018–N–1564]
Ferndale Laboratories, Inc., et al.;
Withdrawal of Approval of Nine
Abbreviated New Drug Applications
AGENCY:
ACTION:
Food and Drug Administration,
Notice.
The Food and Drug
Administration (FDA or Agency) is
withdrawing approval of nine
abbreviated new drug applications
(ANDAs) from multiple applicants. The
SUMMARY:
PO 00000
Frm 00108
Fmt 4703
Sfmt 4703
holders of the applications notified the
Agency in writing that the drug
products were no longer marketed and
requested that the approval of the
applications be withdrawn.
DATES: Approval is withdrawn as of
June 4, 2018.
FOR FURTHER INFORMATION CONTACT:
Trang Tran, Center for Drug Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 75, Rm. 1671, Silver Spring,
MD 20993–0002, 240–402–7945,
Trang.Tran@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The
holders of the applications listed in the
table have informed FDA that these drug
products are no longer marketed and
E:\FR\FM\04MYN1.SGM
04MYN1
Agencies
[Federal Register Volume 83, Number 87 (Friday, May 4, 2018)]
[Notices]
[Pages 19785-19787]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09532]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1707-N]
Medicare Program: Announcement of the Advisory Panel on Hospital
Outpatient Payment (the Panel) Meeting on August 20-21, 2018
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (DHHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the annual meeting of the Advisory Panel
on Hospital Outpatient Payment (the Panel) for 2018. The purpose of the
Panel is to advise the Secretary of Department of Health and Human
Services and the Administrator of the Centers for Medicare & Medicaid
Services concerning the clinical integrity of the Ambulatory Payment
Classification groups and their associated weights as well as hospital
outpatient therapeutic services supervision issues. The advice provided
by the Panel will be considered as we prepare the annual updates for
the hospital outpatient prospective payment system.
DATES:
Meeting Dates: Monday, August 20, 2018, 9:30 a.m. to 5 p.m. EDT
through Tuesday, August 21, 2018, 9:30 a.m. to 1 p.m. EDT.
The times listed in this notice are Eastern Daylight Time (EDT) and
are approximate times. Consequently, the meetings may last longer or be
shorter than the times listed in this notice, but will not begin before
the posted times:
Meeting Information Updates: The actual meeting hours and days will
be posted in the agenda. As information and updates regarding the
onsite, webcast, and teleconference meeting and the agenda become
available, they will be posted to our website at: https://cms.gov/Regulations-and-Guidance/Guidance/FACA/AdvisoryPanelonAmbulatoryPaymentClassificationGroups.html.
Deadline for Presentations and Comments: Presentations or comments
and form CMS-20017, (located at https://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/downloads/cms20017.pdf) must be received by 5 p.m. EDT,
Monday, July 23, 2018. Presentations and comments that are not received
by the due date and time will be considered late and will not be
included on the agenda. In commenting, refer to file code CMS-1707-N.
Meeting Registration Timeframe: Monday, June 25, 2018, through
Monday, July 30, 2018 at 5 p.m. EDT.
Participants planning to attend this meeting in person must
register online, during the specified timeframe at: https://www.cms.gov/apps/events/default.asp. On this web page, double click the
``Upcoming Events'' hyperlink, and then double click the ``HOP Panel''
event title link and enter the required information. Include any
requests for special accommodations.
Note: Participants who do not plan to attend the meeting in
person should not register. No registration is required for
participants who plan to participate in the meeting via webcast or
teleconference.
Because of staff and resource limitations, we cannot accept
comments and presentations by facsimile (FAX) transmission.
Deadline for Requesting Special Accommodations: Monday, July 30,
2018 at 5 p.m. EDT.
ADDRESSES:
Meeting Location, Webcast, and Teleconference.
The meeting will be held in the Auditorium at the CMS Single Site
campus, 7500 Security Boulevard, Baltimore, MD 21244. Alternately, the
public may either view this meeting via a webcast or listen by
teleconference. During the scheduled meeting, webcasting is accessible
online at: https://cms.gov/live. Teleconference dial-in information will
appear on the final meeting agenda, which will be posted on our website
when available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/AdvisoryPanelonAmbulatoryPaymentClassificationGroups.html.
News Media. Press inquiries are handled through the CMS Press
Office at (202) 690-6145.
Advisory Committees' Information Lines. The phone number for the
CMS Federal Advisory Committee Hotline is (410) 786-3985.
Websites. For additional information on the Panel, including the
Panel charter, and updates to the Panel's activities, we refer readers
to view our website at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/AdvisoryPanelonAmbulatoryPaymentClassificationGroups.html.
Information about the Panel and its membership in the Federal
Advisory Committee Act database are also located at: https://facadatabase.gov/.
Registration: The meeting is open to the public; but attendance is
limited to the space available and registration is required. Priority
will be given to those who pre-register and attendance may be limited
based on the number of registrants and the space available.
Persons wishing to attend this meeting, which is located on federal
property, must register by following the instructions in the DATES
section of this notice under ``Meeting Registration Timeframe''. A
confirmation email will be sent to the registrants shortly after
completing the registration process.
FOR FURTHER INFORMATION CONTACT: Elise Barringer, Designated Federal
Official (DFO), 410-786-9222, email at [email protected]. Centers
for Medicare & Medicaid Services, 7500 Security Boulevard, Mail Stop:
C4-04-25, Baltimore, MD 21244-1850.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary of the Department of Health and Human Services (DHHS)
is required by section 1833(t)(9)(A) of the Social Security Act (the
Act) and is allowed by section 222 of the Public Health Service Act
(PHS Act) to consult with an expert outside panel, such as the Advisory
Panel on Hospital Outpatient Payment (the Panel), regarding the
clinical integrity of the Ambulatory Payment Classification (APC)
groups and relative payment weights. The Panel is governed by the
provisions of the Federal Advisory Committee Act (Pub. L. 92-463), as
amended (5 U.S.C. Appendix 2), to set forth standards for the formation
and use of advisory panels. We consider the technical advice provided
by the Panel as we prepare the proposed and final rules to update the
Hospital Outpatient Prospective Payment System (OPPS) for the following
calendar year.
II. Meeting Agenda
The agenda for the August 20 through August 21, 2018 Panel meeting
will provide for discussion and comment on the following topics as
designated in the Panel's Charter:
Addressing whether procedures within an APC group are
similar both clinically and in terms of resource use.
Evaluating APC group structure.
Reviewing the packaging of OPPS services and costs,
including the methodology and the impact on APC groups and payment.
Removing procedures from the inpatient-only list for
payment under the OPPS.
Using single and multiple procedure claims data for Center
for Medicare & Medicaid's (CMS') determination of APC group weights.
[[Page 19786]]
Addressing other technical issues concerning APC group
structure.
Recommending the appropriate supervision level (general,
direct, or personal) for individual hospital outpatient therapeutic
services.
The Agenda will be posted on our website at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/AdvisoryPanelonAmbulatoryPaymentClassificationGroups.html approximately
1 week before the meeting.
III. Presentations
The subject matter of any presentation and comment matter must be
within the scope of the Panel designated in the Charter. Any
presentations or comments outside of the scope of this Panel will be
returned or requested for amendment. Unrelated topics include, but are
not limited to, the conversion factor, charge compression, revisions to
the cost report, pass-through payments, correct coding, new technology
applications (including supporting information/documentation), provider
payment adjustments, supervision of hospital outpatient diagnostic
services, and the types of practitioners that are permitted to
supervise hospital outpatient services. The Panel may not recommend
that services be designated as nonsurgical extended duration
therapeutic services.
The Panel may use data collected or developed by entities and
organizations other than DHHS and CMS in conducting its review. We
recommend organizations submit data for CMS staff and the Panel's
review.
All presentations are limited to 5 minutes, regardless of the
number of individuals or organizations represented by a single
presentation. Presenters may use their 5 minutes to represent either 1
or more agenda items.
Section 508 Compliance
For this meeting, we are aiming to have all presentations and
comments available on our website. Materials on our website must be
Section 508 compliant to ensure access to federal employees and members
of the public with and without disabilities. We encourage presenters
and commenters to reference the guidance on making documents Section
508 compliant as they draft their submissions, and, whenever possible,
to submit their presentations and comments in a 508 compliant form.
Such guidance is available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/CMS-Information-Technology/Section508/508-Compliant-doc.html. We will review presentations and comments for 508 compliance
and place compliant materials on our website. As resources permit, we
will also convert non-compliant submissions to 508 compliant forms and
offer assistance to submitters who wish to make their submissions 508
compliant. All non-508 compliant presentations and comments will be
shared with the public onsite and through the webcast and made
available to the public upon request.
Those wishing to access such materials should contact the DFO (the
DFO's address, email, and phone number are provided in the FOR FURTHER
INFORMATION CONTACT section of this notice).
In order to consider presentations and/or comments, we will need to
receive the following:
1. An email copy of the presentation or comments sent to the DFO
mailbox, [email protected] or, if unable to submit by email, a hard
copy sent to the DFO at the address noted in the FOR FURTHER
INFORMATION CONTACT section of this notice.
2. Form CMS-20017 with complete contact information that includes
name, address, phone number, and email addresses for all presenters and
commenters and a contact person that can answer any questions, and
provide revisions that are requested, for the presentation. Presenters
and commenters must clearly explain the actions that they are
requesting CMS to take in the appropriate section of the form. A
presenter's or commenter's relationship with the organization that they
represent must also be clearly listed.
The form is now available through the CMS Forms website
at: https://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/downloads/cms20017.pdf.
We encourage presenters to make efforts to ensure that
their presentations and comments are 508 compliant.
IV. Oral Comments
In addition to formal oral presentations (limited to 5 minutes
total per presentation), there will be an opportunity during the
meeting for public oral comments (limited to 1 minute for each
individual) and a total of 3 minutes per organization.
V. Panel Recommendations and Discussions
The Panel's recommendations at any Panel meeting generally are not
final until they have been reviewed and approved by the Panel on the
last day of the meeting, before the final adjournment. These
recommendations will be posted to our website after the meeting.
VI. Security, Building, and Parking Guidelines
The meeting is open to the public, but attendance is limited to the
space available. Persons wishing to attend this meeting must register
by contacting the DFO at the address listed in the ADDRESSES section of
this notice or by telephone at the number listed in the FOR FURTHER
INFORMATION CONTACT section of this notice by the date specified in the
DATES section of this notice.
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. We recommend that
confirmed registrants arrive reasonably early, but no earlier than 45
minutes prior to the start of the meeting, to allow additional time to
clear security. Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means
of all persons brought entering the building. We note that all items
brought into CMS, whether personal or for the purpose of presentation
or to support a presentation, are subject to inspection. We cannot
assume responsibility for coordinating the receipt, transfer,
transport, storage, set-up, safety, or timely arrival of any personal
belongings or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45
minutes prior to the convening of the meeting.
All visitors must be escorted in areas other than the lower and
first floor levels in the Central Building.
VII. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
[[Page 19787]]
Dated: April 23, 2018.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2018-09532 Filed 5-3-18; 8:45 am]
BILLING CODE 4120-01-P